Eli Lilly EBIT 2012-2026 | LLY

Eli Lilly EBIT for the quarter ending March 31, 2026 was $8.915B, a 141.27% increase year-over-year.

  • Eli Lilly 2025 EBIT was 26.302B, a 103.91% increase from 2024.
  • Eli Lilly 2024 EBIT was 12.899B, a 99.74% increase from 2023.
  • Eli Lilly 2023 EBIT was 6.458B, a 9.39% decline from 2022.

EBIT can be defined as earnings before interest and taxes.

Eli Lilly EBIT 2012-2026 | LLY

  • Eli Lilly 2025 EBIT was 26.302B, a 103.91% increase from 2024.
  • Eli Lilly 2024 EBIT was 12.899B, a 99.74% increase from 2023.
  • Eli Lilly 2023 EBIT was 6.458B, a 9.39% decline from 2022.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B